Loading…
Aro Biotherapeutics is a biotechnology company developing tissue-targeted genetic medicines using its proprietary Centyrin protein technology. The company creates Centyrin-RNA drug conjugates to precisely modulate gene targets in disease tissues for treating intractable diseases.
AI named ABX1100 in December 2025.